Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
Acta Pharmaceutica Sinica ; (12): 255-259, 2003.
Article in English | WPRIM | ID: wpr-251130

ABSTRACT

<p><b>AIM</b>To study the antidiabetic effects of cortex Moutan polysaccharide-2b (CMP-2b) in type 2 diabetes mellitus (T2DM) rats.</p><p><b>METHODS</b>The T2DM model rats were induced by a single intravenous injection of low dose streptozotocin (STZ) and intake of high sucrose-fat diet. CMP-2b was given to T2DM rats daily through gavage for 4-5 weeks. The body weight, water and food intake, fasting blood glucose (FBG), glucose tolerance, plasma lipids, serum insulin, and insulin receptor (Ins R) were determined.</p><p><b>RESULTS</b>Oral administration of CMP-2b significantly decreased water and food intake, FBG, total cholesterol (Tch), and triglyceride (TG), improved the impaired glucose tolerance (IGT), and remarkably raised the number of low affinity InsR and insulin sensitivity index (ISI) in T2DM rats.</p><p><b>CONCLUSION</b>CMP-2b may be useful for treating T2DM and its complications.</p>


Subject(s)
Animals , Male , Rats , Blood Glucose , Metabolism , Body Weight , Diabetes Mellitus, Experimental , Drug Therapy , Drugs, Chinese Herbal , Chemistry , Glucose Intolerance , Hypoglycemic Agents , Therapeutic Uses , Insulin , Blood , Liver , Metabolism , Paeonia , Chemistry , Plant Roots , Chemistry , Plants, Medicinal , Chemistry , Polysaccharides , Therapeutic Uses , Rats, Wistar , Receptor, Insulin , Metabolism
2.
China Journal of Chinese Materia Medica ; (24): 1181-1183, 2003.
Article in Chinese | WPRIM | ID: wpr-293698

ABSTRACT

<p><b>OBJECTIVE</b>To study the protective effect of Ligustrazine on IR after local cerebral ischemia of rat.</p><p><b>METHOD</b>Models of rat IR after local cerebral ischemia were prepared by electrocagulation of the middle cerebral artery, and changes of serum insulin, tomer necrosis factor-alpha (TNF-alpha), plasma endothelin-1 (ET-1), nitric oxide (NO) and nitric oxide synthase (NOS) were observed 2 weeks after the ischemia.</p><p><b>RESULT</b>Ligustrazine could significantly reduce serum insulin (P < 0.01), the content of plasma ET-1 (P < 0.01) and serum TNF-alpha (P < 0.01), the activity of brain tissue NO and NOS (P < 0.01). The drug also increased insulin sensitivity indexes (ISI).</p><p><b>CONCLUSION</b>The protective effects of Ligustrazion on IR cerebral ischemia may be related to decreasing ET-1 content in plasma, TNF-alpha content in serum, NO content and NOS activities in tissue.</p>


Subject(s)
Animals , Female , Male , Rats , Brain Ischemia , Blood , Endothelin-1 , Blood , Infarction, Middle Cerebral Artery , Insulin , Blood , Insulin Resistance , Neuroprotective Agents , Pharmacology , Pyrazines , Pharmacology , Random Allocation , Rats, Sprague-Dawley , Superoxide Dismutase , Blood , Tumor Necrosis Factor-alpha , Metabolism
SELECTION OF CITATIONS
SEARCH DETAIL